268 filings
Page 5 of 14
8-K
jbz2u4g0
4 Mar 21
Larimar Therapeutics Reports Fourth Quarter and Full Year 2020 Operating and Financial Results
7:30am
8-K
q8wc 2zwl
8 Dec 20
Regulation FD Disclosure
7:40am
8-K/A
k8cjn3gw
12 Nov 20
Unaudited Pro Forma Combined Financial Statements
4:51pm
8-K
1qksb
10 Nov 20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
4:23pm
8-K
9cfrr14
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm
S-8
4v6p5enbvas i2v
2 Oct 20
Registration of securities for employees
5:19pm
8-K/A
xsl7zod
29 Sep 20
Departure of Directors or Certain Officers
4:39pm
8-K
kbkse 88qq19fiz
29 Sep 20
Departure of Directors or Certain Officers
7:06am
EFFECT
0n3s xhxq
2 Sep 20
Notice of effectiveness
12:15am
CORRESP
4e1vlrexzt7ulug0xf
31 Aug 20
Correspondence with SEC
12:00am
UPLOAD
v8b 9heml27dl9we6
24 Aug 20
Letter from SEC
12:00am
DEFA14A
8m2 mjwrz
19 Aug 20
Additional proxy soliciting materials
6:13am
8-K/A
itlyvaulc0aeo
14 Aug 20
Unaudited Pro Forma Combined Financial Statements
4:56pm
8-K
tz6pbu
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K
se34rre0
6 Aug 20
Departure of Directors or Certain Officers
9:00am
EFFECT
x7atk6r00axrups0n4lh
15 Jul 20
Notice of effectiveness
12:15am